Literature DB >> 26856781

Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia.

F F Peres1, M C Diana2, M A Suiama2, V Justi2, V Almeida2, R A Bressan3, A W Zuardi4, J E Hallak4, J A Crippa4, V C Abilio2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26856781     DOI： 10.1016/j.schres.2016.02.004

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  12 in total

Review 1.  Cannabinoids and glial cells: possible mechanism to understand schizophrenia.

Authors:  Valéria de Almeida; Daniel Martins-de-Souza
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-02-01       Impact factor: 5.270

2.  Commentary on "The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis".

Authors:  Philip McGuire; Amir Englund; Sagnik Bhattacharyya
Journal:  Schizophr Bull       Date:  2018-01-13       Impact factor: 9.306

Review 3.  Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies.

Authors:  Vamsi Reddy; Dayton Grogan; Meenakshi Ahluwalia; Évila Lopes Salles; Pankaj Ahluwalia; Hesam Khodadadi; Katelyn Alverson; Andy Nguyen; Srikrishnan P Raju; Pankaj Gaur; Molly Braun; Fernando L Vale; Vincenzo Costigliola; Krishnan Dhandapani; Babak Baban; Kumar Vaibhav
Journal:  EPMA J       Date:  2020-04-15       Impact factor: 6.543

4.  Compared to high and low cannabis use, moderate use is associated with fewer cognitive deficits in psychosis.

Authors:  Ashley M Schnakenberg Martin; Kelsey A Bonfils; Beshaun J Davis; Elizabeth A Smith; Kelly Schuder; Paul H Lysaker
Journal:  Schizophr Res Cogn       Date:  2016-10-10

5.  Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model.

Authors:  Ashleigh L Osborne; Nadia Solowij; Ilijana Babic; Xu-Feng Huang; Katrina Weston-Green
Journal:  Neuropsychopharmacology       Date:  2017-02-23       Impact factor: 7.853

Review 6.  Cannabidiol as a potential treatment for psychosis.

Authors:  Cathy Davies; Sagnik Bhattacharyya
Journal:  Ther Adv Psychopharmacol       Date:  2019-11-08

7.  Botanically-Derived Δ9-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple Sclerosis.

Authors:  John-Mark Fitzpatrick; Becky Hackett; Lisa Costelloe; William Hind; Eric J Downer
Journal:  Molecules       Date:  2022-03-08       Impact factor: 4.411

8.  Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia.

Authors:  Fernanda F Peres; Mariana C Diana; Raquel Levin; Mayra A Suiama; Valéria Almeida; Ana M Vendramini; Camila M Santos; Antônio W Zuardi; Jaime E C Hallak; José A Crippa; Vanessa C Abílio
Journal:  Front Pharmacol       Date:  2018-08-21       Impact factor: 5.810

Review 9.  Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age.

Authors:  José A Crippa; Francisco S Guimarães; Alline C Campos; Antonio W Zuardi
Journal:  Front Immunol       Date:  2018-09-21       Impact factor: 7.561

Review 10.  Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant.

Authors:  Elaine C D Gonçalves; Gabriela M Baldasso; Maíra A Bicca; Rodrigo S Paes; Raffaele Capasso; Rafael C Dutra
Journal:  Molecules       Date:  2020-03-29       Impact factor: 4.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.